Literature DB >> 23627825

The potential of stem cells for the restoration of auditory function in humans.

Zhengqing Hu1, Mats Ulfendahl.   

Abstract

Hearing loss is one of the most common disabilities, affecting approximately 10% of the population. Hair cells and spiral ganglion neurons are usually damaged in most cases of hearing loss. Currently, there is virtually no biological approach to replace damaged hearing cells. Recent developments in stem cell technology provide new opportunities for the treatment of deafness. Two major strategies have been investigated: differentiation of endogenous stem cells into new hair cells; and introduction of exogenous cells into the inner ear to substitute injured hearing neurons. Although there is still a learning curve in stem cell-based replacement, the probability exists to utilize personalized stem cells to eventually provide a novel intervention for patients with deafness in future clinical research trials.

Entities:  

Mesh:

Year:  2013        PMID: 23627825      PMCID: PMC3802542          DOI: 10.2217/rme.13.32

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  85 in total

1.  Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4.

Authors:  J Nichols; B Zevnik; K Anastassiadis; H Niwa; D Klewe-Nebenius; I Chambers; H Schöler; A Smith
Journal:  Cell       Date:  1998-10-30       Impact factor: 41.582

2.  Regenerative proliferation in organ cultures of the avian cochlea: identification of the initial progenitors and determination of the latency of the proliferative response.

Authors:  M E Warchol; J T Corwin
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

3.  Complementary roles of BDNF and NT-3 in vestibular and auditory development.

Authors:  P Ernfors; T Van De Water; J Loring; R Jaenisch
Journal:  Neuron       Date:  1995-06       Impact factor: 17.173

4.  New hair cells arise from supporting cell conversion in the acoustically damaged chick inner ear.

Authors:  H J Adler; Y Raphael
Journal:  Neurosci Lett       Date:  1996-02-16       Impact factor: 3.046

5.  Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells.

Authors:  Marvin C Gershengorn; Anandwardhan A Hardikar; Chiju Wei; Elizabeth Geras-Raaka; Bernice Marcus-Samuels; Bruce M Raaka
Journal:  Science       Date:  2004-11-25       Impact factor: 47.728

6.  NGF stimulates extensive neurite outgrowth from implanted dorsal root ganglion neurons following transplantation into the adult rat inner ear.

Authors:  Zhengqing Hu; Mats Ulfendahl; N Petri Olivius
Journal:  Neurobiol Dis       Date:  2005-02       Impact factor: 5.996

7.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

8.  Regenerative proliferation in inner ear sensory epithelia from adult guinea pigs and humans.

Authors:  M E Warchol; P R Lambert; B J Goldstein; A Forge; J T Corwin
Journal:  Science       Date:  1993-03-12       Impact factor: 47.728

9.  Replacement of hair cells after laser microbeam irradiation in cultured organs of corti from embryonic and neonatal mice.

Authors:  M W Kelley; D R Talreja; J T Corwin
Journal:  J Neurosci       Date:  1995-04       Impact factor: 6.167

10.  Survival and neural differentiation of adult neural stem cells transplanted into the mature inner ear.

Authors:  Zhengqing Hu; Dongguang Wei; Clas B Johansson; Niklas Holmström; Maoli Duan; Jonas Frisén; Mats Ulfendahl
Journal:  Exp Cell Res       Date:  2005-01-01       Impact factor: 3.905

View more
  14 in total

Review 1.  Gene therapy for hearing loss.

Authors:  Ryotaro Omichi; Seiji B Shibata; Cynthia C Morton; Richard J H Smith
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

Review 2.  Pluripotent stem cell-derived cochlear cells: a challenge in constant progress.

Authors:  Amandine Czajkowski; Anaïs Mounier; Laurence Delacroix; Brigitte Malgrange
Journal:  Cell Mol Life Sci       Date:  2018-10-19       Impact factor: 9.261

3.  Identification of Neural Stem Cells from Postnatal Mouse Auditory Cortex In Vitro.

Authors:  Zhengqing Hu; Li Tao; Zhenjie Liu; Yiyun Jiang; Xin Deng
Journal:  Stem Cells Dev       Date:  2019-05-29       Impact factor: 3.272

Review 4.  CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss.

Authors:  Rimsha Farooq; Khadim Hussain; Muhammad Tariq; Ali Farooq; Muhammad Mustafa
Journal:  J Appl Genet       Date:  2020-01-07       Impact factor: 3.240

Review 5.  New treatment options for hearing loss.

Authors:  Ulrich Müller; Peter G Barr-Gillespie
Journal:  Nat Rev Drug Discov       Date:  2015-03-20       Impact factor: 84.694

6.  Genome-wide demethylation by 5-aza-2'-deoxycytidine alters the cell fate of stem/progenitor cells.

Authors:  Yang Zhou; Zhengqing Hu
Journal:  Stem Cell Rev Rep       Date:  2015-02       Impact factor: 5.739

7.  An engineered three-dimensional stem cell niche in the inner ear by applying a nanofibrillar cellulose hydrogel with a sustained-release neurotrophic factor delivery system.

Authors:  Hsiang-Tsun Chang; Rachel A Heuer; Andrew M Oleksijew; Kyle S Coots; Christian B Roque; Kevin T Nella; Tammy L McGuire; Akihiro J Matsuoka
Journal:  Acta Biomater       Date:  2020-03-07       Impact factor: 8.947

8.  Histone deacetylase inhibitor induces the expression of select epithelial genes in mouse utricle sensory epithelia-derived progenitor cells.

Authors:  Zhengqing Hu; Jue Wang
Journal:  Cell Reprogram       Date:  2014-06-19       Impact factor: 1.987

Review 9.  Genetics of Hearing Loss: Syndromic.

Authors:  Tal Koffler; Kathy Ushakov; Karen B Avraham
Journal:  Otolaryngol Clin North Am       Date:  2015-10-09       Impact factor: 3.346

10.  Phosphodiesterase type 4 inhibitor rolipram improves survival of spiral ganglion neurons in vitro.

Authors:  Katharina Kranz; Athanasia Warnecke; Thomas Lenarz; Martin Durisin; Verena Scheper
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.